Delivery Order SPE2DB20D1004-SPE2DB22FG0F9

Award Date 8/9/22
Potential Completion Date 8/10/22
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $17,401.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This federal contract award is for the delivery of Xarelto 2.5 mg tablets to the Defense Logistics Agency (DLA). The $1,381.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 19, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $25,702.98 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 16, 2022 with a completion date of June 17, 2022. The contract is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,036.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm-fixed-price delivery order with a completion date of January 19, 2024. The award was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $36,716.71 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of Xarelto 20mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $10,697.34. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is associated with a larger...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $19,404.28 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 4, 2022, with a completion date of August 5, 2022. This order is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that covers a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $1,409.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 29, 2023. The contract has a completion date of June 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $6,131.46 delivery order is issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a subordinate command of the Defense Logistics Agency responsible for providing medical supplies to the U.S. military and other federal agencies. The contract, valued at $5,653.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FG0F9
    Delivery Order

This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $3,072.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 2/27/25, 10:21 AM